Have a personal or library account? Click to login
Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery Cover

Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery

Acta Pharmaceutica
Volume 65 (2015): Issue 1 (March 2015)
By: Ümit Gönüllü,  Melike Üner,  Gülgün Yener,  Ecem Fatma Karaman and  Zeynep Aydoğmuş  
Open Access
|Mar 2015

References

  1. 1. The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals (Ed. M. J. O’Neil), 14th ed., Merck Publishing Group, Merck & Co., Inc., Whitehouse Station 2006.
    Search in Google Scholar
  2. 2. D. S. P. Byrav, B. Medhi, A. Prakash, S. Patyar and S. Wadhwa, Lornoxicam: A newer NSAID, Indian J. Phys. Med. Rehabil. 20 (2009) 27-31.
    Search in Google Scholar
  3. 3. F. B. Riecke, E. M. Bartels, S. Torp-Pedersen, S. Ribel-Madsen, H. Bliddal, B. Danneskiold-Samsoe and L. Arendt-Nielsen, A microdialysis study of topically applied diclofenac to healthy humans: Passive versus iontophoretic delivery, Res. Pharm. Sci. 1 (2011) 76-79; DOI: 10.1016/j. rinphs.2011.11.001.
    Search in Google Scholar
  4. 4. G. Yener, M. Uner, U. Gonullu, S. Yıldırım, P. Kılıc, S. Sağlık Aslan and A. Barla, Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies, Chem. Pharm. Bull. 58 (2010) 1466-1473; DOI: 10.1248/cpb.58.1466.10.1248/cpb.58.1466
    Search in Google Scholar
  5. 5. M. Uner, Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): Their benefits as colloidal drug carrier systems, Pharmazie 61 (2006) 375-386.
    Search in Google Scholar
  6. 6. M. Uner and G. Yener, Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives, Int. J. Nanomed. 2 (2007) 289-300.
    Search in Google Scholar
  7. 7. S. A. Wissing, A. Lippacher and R. H. Muller, Investigations on the occlusive properties of solid lipid nanoparticles (SLN), J. Cosmet. Sci. 52 (2001) 313-324.
    Search in Google Scholar
  8. 8. H. Chen, X. Chang, D. Du, W. Liu, J. Liu, T. Weng, Y. Yang, H. Xu and X. Yang, Podophyllotoxinloaded solid lipid nanoparticles for epidermal targeting, J. Control. Release 110 (2006) 296-306; DOI: 10.1016/j.jconrel.2005.09.052.10.1016/j.jconrel.2005.09.052
    Search in Google Scholar
  9. 9. C. Puglia, P. Blasi, L. Rizza, A. Schoubben, F. Bonina, C. Rossi and M. Ricci, Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation, Int. J. Pharm. 357 (2008) 295-304; DOI: 10.1016/j.ij pharm.2008.01.045.
    Search in Google Scholar
  10. 10. S. Kuchler, N. B. Wolf, S. Heilmann, G. Weindl, J. Helfmann, M. M. Yahya, C. Stein and M. Schafer- Korting, 3D-wound healing model: influence of morphine and solid lipid nanoparticles, J. Biotechnol. 148 (2010) 24-30; DOI: 10.1016/j.jbiotec.2010.01.001.10.1016/j.jbiotec.2010.01.001
    Search in Google Scholar
  11. 11. V. Sanna, G. Caria and A. Mariani, Eff ect of lipid nanoparticles containing fa_ y alcohols having diff erent chain length on the ex vivo skin permeability of econazole nitrate, Powder Technol. 201 (2010) 32-36; DOI: 10.1016/j.powtec.2010.02.035. 10.1016/j.powtec.2010.02.035
    Search in Google Scholar
  12. 12. E. B. Souto, C. Anselmi, M. Centini and R. H. Muller, Preparation and characterization of n-dodecyl- ferulate-loaded solid lipid nanoparticles (SLNR), Int. J. Pharm. 295 (2005) 261-268; DOI: 10.1016/j.ij pharm.2005.02.005.
    Search in Google Scholar
  13. 13. M. Ghadiri, S. Fatemi, A. Vatanara, D. Doroud, A. R. Najafabadi, M. Darabi and A. A. Rahimi, Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modeling of entrapment effi ciency and particle size, Int. J. Pharm. 424 (2012) 128-137; DOI: 10.1016/j.ij pharm.2011.12.037.
    Search in Google Scholar
  14. 14. Y. C. Kuo and H. H. Chen, Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles, Int. J. Pharm. 365 (2009) 206-213; DOI: 10.1016/j.ij pharm.2008.08.050.
    Search in Google Scholar
  15. 15. O. W. Sto_ , A. C. Williams and B. W. Barry, Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen, J. Control. Release 50 (1998) 297-308; DOI: 10.1016/S0168-3659(97)00153-3.10.1016/S0168-3659(97)00153-3
    Search in Google Scholar
  16. 16. J. L. Ford and P. Timmins, Pharmaceutical Thermal Analysis, Ellis Horwood, Chichester 1989.
    Search in Google Scholar
  17. 17. B. Siekmann and K. Westesen, Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles, Colloids Surf., B. Biointerfaces 3 (1994) 159-175; DOI: 10.1016/0927-7765(94)80063-4.10.1016/0927-7765(94)80063-4
    Search in Google Scholar
  18. 18. J. Pardeike, S. Webera, T. Haber, J. Wagner, H. P. Zarfl , H. Plank and A. Zimmer, Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application, Int. J. Pharm. 419 (2011) 329-338; DOI: 10.1016/j.ij pharm.2011.07.040.
    Search in Google Scholar
  19. 19. D. Z. Hou, C. S. Xie, K. J. Huang and C. H. Zhu, The production and characteristics of solid-lipid nanoparticles (SLNs), Biomaterials 34 (2003) 1781-1785; DOI: 10.1016/S0142-9612(02)00578-1.10.1016/S0142-9612(02)00578-1
    Search in Google Scholar
  20. 20. S. Das, W. K. Ng and R. B. H. Tan, Are nanostructured lipid carriers (NLCs) be_ er that solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole- loaded SLNs and NLCs?, Eur. J. Pharm. Sci. 47 (2012) 139-151; DOI: 10.1016/j.ejps.2012.05.010.10.1016/j.ejps.2012.05.010
    Search in Google Scholar
  21. 21. P. Costa and J. M. Sousa Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1
    Search in Google Scholar
  22. 22. R. W. Korsmeyer, R. Gurney, E. M. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35. DOI: 10.1016/0378-5173(83)90064-9.10.1016/0378-5173(83)90064-9
    Search in Google Scholar
  23. 23. J. Y. Fang, C. L. Fang, C. H. Liu and Y. H. Su, Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC), Eur. J. Pharm. Biopharm. 70 (2008) 633-640; DOI: 10.1016/j.ejpb.2008.05.008.10.1016/j.ejpb.2008.05.008
    Search in Google Scholar
  24. 24. M. Joshi and V. Patravale, Nanostructured lipid carrier (NLC) based gel of celecoxib, Int. J. Pharm. 346 (2008) 124-132; DOI: 10.1016/j.ij pharm.2007.05.060.
    Search in Google Scholar
  25. 25. A. Zur Muhlen, C. Schwarz and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism, Eur. J. Pharm. Biopharm. 45 (1998) 149-155; DOI: 10.1016/S0939-6411(97)00150-1.10.1016/S0939-6411(97)00150-1
    Search in Google Scholar
  26. 26. K. Bhaskar, J. Anbu, V. Ravichandiran, V. Venkatesvarlu and Y. M. Rao, Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies, Lipids Health Dis. 8 (2009) 1-15; DOI: 10.1186/1476-511X-8-6.10.1186/1476-511X-8-6265188119243632
    Search in Google Scholar
  27. 27. S. K. Jain, M. K. Chourasia, R. Masuriha, V. Soni, A. Jain, N. K. Jain and Y. Gupta, Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery, Drug Deliv. 12 (2005) 207-215; DOI: 10.1080/10717540590952591. 10.1080/1071754059095259116036715
    Search in Google Scholar
DOI: https://doi.org/10.1515/acph-2015-0009 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 1 - 13
Submitted on: Oct 23, 2014
Published on: Mar 11, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
lornoxicam,
solid lipid nanoparticles,
nanostructured lipid carriers,
nanoemulsion,
transdermal delivery,
inflammation
Related subjects:
Pharmacy,
Pharmacy, other

© 2015 Ümit Gönüllü, Melike Üner, Gülgün Yener, Ecem Fatma Karaman, Zeynep Aydoğmuş, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 65 (2015): Issue 1 (March 2015)Next article